Xylitol-induced elevated expression of the gbpC gene in a population of Streptococcus mutans cells.
Xylitol possesses a unique property distinct from the other caries-preventive sweeteners. This sugar alcohol cannot be metabolized to acids but is taken up by Streptococcus mutans and accumulated as a toxic sugar-phosphate in the cells, resulting in growth inhibition. Due to the accumulation, xylitol induces biological responses including the emergence of xylitol-insensitive populations. Therefore, we expected another response induced by xylitol and found a new phenomenon, that cells repeatedly cultured in the presence of xylitol evolved into those exhibiting an elevated dextran-dependent aggregation phenotype. This phenotype was found to result from expression of the gbpC gene, which was previously reported to be expressed only under certain stress conditions. Construction of a Strep. mutans isogenic mutant carrying the gbpC::lacZ fusion gene indicated that gbpC expression of cells repeatedly cultured in the presence of xylitol was elevated 20-fold. DNA transfer experiments indicated that this phenotypic change did not appear to be due to a mutation. These cells also exhibited decreased adhesion to glass surfaces when grown in the presence of sucrose. This may be one of the ways by which some populations of Strep. mutans are removed from dental plaques.
Sato
Y
Y
Department of Biochemistry, Tokyo Dental College, Chiba City, Japan. yusato@tdc.ac.jp
Yamamoto
Y
Y
Kizaki
H
H
D000222:Adaptation, Physiological / Q000235:genetics; D019677:Artificial Gene Fusion; D001422:Bacterial Adhesion / Q000235:genetics; D001426:Bacterial Proteins / Q000187:drug effects* / Q000235:genetics; D002327:Cariostatic Agents / Q000494:pharmacology*; D002352:Carrier Proteins / Q000187:drug effects* / Q000235:genetics; D002478:Cells, Cultured; D003470:Culture Media; D003773:Dental Plaque / Q000382:microbiology; D003911:Dextrans / Q000494:pharmacology; D015964:Gene Expression Regulation, Bacterial / Q000187:drug effects; D005936:Glucans / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007763:Lac Operon / Q000235:genetics; D037102:Lectins; D009154:Mutation / Q000235:genetics; D010641:Phenotype; D013295:Streptococcus mutans / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development; D016986:Streptococcus sobrinus / Q000187:drug effects / Q000235:genetics / Q000254:growth & development; D013395:Sucrose / Q000494:pharmacology; D013549:Sweetening Agents / Q000494:pharmacology*; D014993:Xylitol / Q000494:pharmacology*; D001616:beta-Galactosidase / Q000235:genetics / Q000378:metabolism
D001426:Bacterial Proteins; D002327:Cariostatic Agents; D002352:Carrier Proteins; D003470:Culture Media; D003911:Dextrans; D005936:Glucans; D037102:Lectins; D013549:Sweetening Agents; C037937:glucan-binding proteins; D013395:Sucrose; D001616:beta-Galactosidase; D014993:Xylitol